Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks

Clinical trial NCT07093138 · RECRUITING

Trial details

NCT number: NCT07093138
Sponsor: Alasht Pharmed
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2025-07-16
Primary completion: 2025-09-16
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.